4.74
0.02 (0.42%)
0.02 (0.42%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.22 | -4.45% | 4.72 | 4.66 | 4.92 | 4.91 | 4.94 | 00:00:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.50 | 5.02 | 0.52 | 10.36% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 813 | 211,611 | $ 4.76 | $ 1,007,269 | 684,570 | 2.0001 - 8.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:27:06 | formt | 200 | $ 4.74 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 17.75M | 3.76M | -92.84 | - | 2.81M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.02 | 5.49 | 4.62 | 4.85 | 192,722 | -0.30 | -5.98% |
| 1 Month | 5.24 | 7.50 | 4.51 | 5.57 | 915,709 | -0.52 | -9.92% |
| 3 Months | 6.5097 | 7.60 | 4.51 | 5.78 | 639,675 | -1.79 | -27.49% |
| 6 Months | 2.46 | 8.35 | 2.03 | 4.54 | 1,077,236 | 2.26 | 91.87% |
| 1 Year | 3.11 | 8.35 | 2.0001 | 4.46 | 978,924 | 1.61 | 51.77% |
| 3 Years | 3.11 | 8.35 | 2.0001 | 4.46 | 978,924 | 1.61 | 51.77% |
| 5 Years | 3.11 | 8.35 | 2.0001 | 4.46 | 978,924 | 1.61 | 51.77% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. The company's cyclophilin inhibitor, CRV431 targets multiple biochemical pathways involved in the progression of liver disease. |
